SCHEMBL23787638

SCHEMBL23787638

Nc1c(S(=O)(=O)O)cc(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)O)c(N)c5ccccc45)c(OC(F)(F)F)c3)cc2OC(F)(F)F)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.50
▸ THRB P10828 5/20 0.50
▸ HPGD P15428 5/20 0.50
▸ RECQL P46063 5/20 0.50
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ MAPT P10636 4/20 0.50
▸ BLM P54132 4/20 0.50
▸ TDP1 Q9NUW8 3/20 0.50
▸ ALOX12 P18054 3/20 0.50
▸ APP P05067 3/20 0.50
▸ SNCA P37840 2/20 0.50
▸ CYP3A4 P08684 5/20 0.47
▸ MAPK1 P28482 5/20 0.47
▸ HSD17B10 Q99714 4/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ ALOX15 P16050 3/20 0.47
▸ TP53 P04637 2/20 0.47
▸ BRCA1 P38398 2/20 0.47
▸ APEX1 P27695 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787624 0.91 ALDH1A1 (0.62) ALDH1A1THRBHPGDRECQLMEN1
SCHEMBL23787576 0.85 THRB (0.64) ALDH1A1THRBHPGDRECQLMEN1
SCHEMBL23787736 0.84 PHLPP2 (0.50) ALDH1A1THRBHPGDRECQLMEN1
SCHEMBL23787779 0.83 THRB (0.41) ALDH1A1THRBHPGDRECQLMEN1
SCHEMBL23787678 0.83 PHLPP2 (0.55) ALDH1A1THRBHPGDRECQLMEN1
SCHEMBL23787517 0.83 ALDH1A1 (0.50) ALDH1A1THRBHPGDRECQLMEN1
SCHEMBL23787546 0.83 ALDH1A1 (0.53) ALDH1A1THRBHPGDRECQLMEN1
SCHEMBL23787787 0.83 THRB (0.43) ALDH1A1THRBHPGDRECQLMEN1
SCHEMBL23787636 0.81 ALDH1A1 (0.56) ALDH1A1THRBHPGDRECQLMEN1
SCHEMBL23787577 0.79 ALDH1A1 (0.65) ALDH1A1THRBHPGDRECQLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 ALDH1A1 3745/4885THRB 2774/4885HPGD 1140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback